Pheochromocytoma—Clinical Manifestations, Diagnosis and Current Perioperative Management
Open Access
- 9 October 2019
- journal article
- review article
- Published by MDPI AG in Journal of Mind and Medical Sciences
- Vol. 6 (2) , 243-247
Abstract
Pheochromocytoma is a neuroendocrine tumor characterized by the excessive production of catecholamines (epinephrine, norepinephrine, and dopamine). The diagnosis is suspected due to hypertensive paroxysms, associated with vegetative phenomena, due to the catecholaminergic hypersecretion. Diagnosis involves biochemical tests that reveal elevated levels of catecholamine metabolites (metanephrine and normetanephrine). Functional imaging, such as 123I-metaiodobenzylguanidine scintigraphy (123I-MIBG), has increased specificity in identifying the catecholamine-producing tumor and its metastases. The gold-standard treatment for patients with pheochromocytoma is represented by the surgical removal of the tumor. Before surgical resection, it is important to optimize blood pressure and intravascular volume in order to avoid negative hemodynamic events.Keywords
This publication has 29 references indexed in Scilit:
- Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytomaSurgery, 2016
- Selective strategy for intensive monitoring after pheochromocytoma resectionSurgery, 2016
- The impact of changes in drug availability for hemodynamic management in pheochromocytoma: prêt-à-porter or tailor-made?Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2015
- Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatmentCurrent Problems in Cancer, 2014
- Prospective Study to Compare Peri‐operative Hemodynamic Alterations following Preparation for Pheochromocytoma Surgery by Phenoxybenzamine or PrazosinWorld Journal of Surgery, 2013
- Screening for Pheochromocytomas and ParagangliomasCurrent Hypertension Reports, 2012
- Cardiovascular complications in patients with pheochromocytoma: A mini-reviewBiomedicine & Pharmacotherapy, 2010
- Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumorJournal of Surgical Oncology, 2005
- Efficacy and Safety of Doxazosin for Perioperative Management of Patients with PheochromocytomaWorld Journal of Surgery, 2002
- Biochemical Diagnosis of PheochromocytomaJAMA, 2002